Ferreira, Glaucio Monteiro 
; Kronenberger, Thales ; Maltarollo, Vinícius Gonçalves ; Poso, Antti ; Gatti, Fernando de Moura ; Almeida, Vitor Medeiros ; Marana, Sandro Roberto ; Lopes, Carla Duque ; Tezuka, Daiane Yukie; Albuquerque, Sérgio de ; Emery, Flavio da Silva ; Trossini, Gustavo Henrique Goulart
Fonte: Pharmaceuticals. Unidades: FCF, IQ, FCFRP
Assuntos: TRYPANOSOMA CRUZI, ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Glaucio Monteiro et al. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, v. 16 , p. 1-14 art. 428, 2023Tradução . . Disponível em: https://doi.org/10.3390/ph16030428. Acesso em: 18 nov. 2024.APA
Ferreira, G. M., Kronenberger, T., Maltarollo, V. G., Poso, A., Gatti, F. de M., Almeida, V. M., et al. (2023). Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design. Pharmaceuticals, 16 , 1-14 art. 428. doi:10.3390/ph16030428NLM
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ph16030428Vancouver
Ferreira GM, Kronenberger T, Maltarollo VG, Poso A, Gatti F de M, Almeida VM, Marana SR, Lopes CD, Tezuka DY, Albuquerque S de, Emery F da S, Trossini GHG. Trypanosoma cruzi Sirtuin 2 as a relevant druggable target: new inhibitors developed by computer-aided drug design [Internet]. Pharmaceuticals. 2023 ; 16 1-14 art. 428.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/ph16030428
